MEDIFAST ($MED) posted quarterly earnings results on Monday, April 28th. The company reported earnings of -$0.11 per share, beating estimates of -$0.27 by $0.16. The company also reported revenue of $115,730,000, beating estimates of $111,201,000 by $4,529,000.
You can see Quiver Quantitative's $MED stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDIFAST Hedge Fund Activity
We have seen 52 institutional investors add shares of MEDIFAST stock to their portfolio, and 75 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC removed 210,214 shares (-54.7%) from their portfolio in Q4 2024, for an estimated $3,703,970
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 180,332 shares (-77.8%) from their portfolio in Q4 2024, for an estimated $3,177,449
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. added 110,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,938,200
- MARSHALL WACE, LLP added 104,226 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,836,462
- RENAISSANCE TECHNOLOGIES LLC removed 102,476 shares (-10.2%) from their portfolio in Q4 2024, for an estimated $1,805,627
- TWO SIGMA ADVISERS, LP added 99,900 shares (+86.0%) to their portfolio in Q4 2024, for an estimated $1,760,238
- UBS GROUP AG added 85,866 shares (+1359.5%) to their portfolio in Q4 2024, for an estimated $1,512,958
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
